Initial IHC analysis of HER2-type human BC specimens in the Oulu cohort (n = 21, Supplemental Table 1) showed that ColXVIII was highly expressed in HER2+ and EGFR+ tumor areas that had a high number of Ki67+ proliferating cells (Figure 2, A and B). This evidence concerns the gene EGFR and breast cancer.